Titolo	Data di pubblicazione	Autore(i)
1	Which breast carcinomas need HER-2/neu gene study after immunohistochemical analysis? Results of combined use of antibodies against different c-erbB2 protein domains.	2003	A. SAPINO; COCCORULLO Z; CASSONI P; GHISOLFI G; GUGLIOTTA P; BONGIOVANNI M; ARISIO R; CRAFA P; BUSSOLATI G
2	What modifies the relation between tumour size and lymph node metastases in T1 breast carcinomas?	2000	ARISIO R; SAPINO A; CASSONI P; ACCINELLI G; CUCCORESE MC; MANO MP; G. BUSSOLATI
3	Well-differentiated neuroendocrine tumour of the breast showing peculiar endovascular spread.	2013	Kawasaki T; Bussolati G; Marchiò C; Castellano I; Daniele L; Molinaro L; Hinata M; Furuya K; Nakagomi H; Oyama T; Tsunoda H; Sugai T; Katoh R; Sapino A.
4	Vinorelbine-based salvage therapy in HER2-positive metastatic breast cancer patients progressing during trastuzumab-containing regimens: a retrospective study	2008	MONTEMURRO F; REDANA S; NOLE' F; DONADIO M; JACOMUZZI ME; VALABREGA G; VIALE G; SAPINO A; AGLIETTA M
5	Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions	2008	Cserni G; Bianchi S; Vezzosi V; van Diest P; van Deurzen C; Sejben I; Regitnig P; Asslaber M; Foschini MP; Sapino A; Castellano I; Callagy G; Arkoumani E; Kulka J; Wells CA
6	Valutazione di parametri predittivi di interessamento dei linfonodi non sentinella e creazione di indice di rischio “pesato” per la prognosi dei pazienti con melanoma in stadio III.	2012	R. Senetta; S. Ribero; G. Macripò; L. Macrì; P. Quaglino; V. Caliendo; MG. Bernengo; S. Pasquali; MC. Montesco; CR. Rossi; A. Sapino
7	Validation of clinical prediction rules for a low probability of nonsentinel and extensive lymph node involvement in breast cancer patients	2007	CSERNI G; BIANCHI S; VEZZOSI V; ARISIO R; PETERSE JL; A. SAPINO; CASTELLANO I; DRIJKONINGEN M; KULKA J; EUSEBI V; FOSCHINI MP; BELLOCQ JP; MARIN C; THORSTENSON; S; AMENDOEIRA I; REINER-CONCIN A; DECKER T; LACERDA M; FIGUEIREDO P
8	Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas	2015	A. Stacchini;D. Pacchioni;A. Demurtas;S. Aliberti;A. Cassenti;G. Isolato;C. Gazzera;A. Veltri;A. Sapino;M. Papotti;M. Freddi;N. Palestini;G. Sisto;D. Novero
9	Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells.	2014	Rondón-Lagos M;Verdun Di Cantogno L;Rangel N;Mele T;Ramírez-Clavijo SR;Scagliotti G;Marchiò C;Sapino A
10	Underuse of Anthracyclines in Women with HER-2+ Advanced Breast Cancer.	2010	Montemurro F; Rossi V; Nolè F; Redana S; Donadio M; Martinello R; Verri E; Valabrega G; Rocca MC; Jacomuzzi ME; Viale G; Sapino A; Aglietta M.
11	Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management.	2003	A. SAPINO; CASSONI P; ZANON E; FRAIRE F; CROCE S; COLUCCIA C; DONADIO M; BUSSOLATI G.
12	Two new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations identified in a cohort of Italian breast and ovarian cancer families.	2014	Vignolo Lutati F; Casalis Cavalchini G; Sapino A; Pasini B
13	Tumour Heterogeneity of Breast Cancer: From Morphology to Personalised Medicine	2018	Aleskandarany, Mohammed A.; Vandenberghe, Michel E.; Marchiò, Caterina; Ellis, Ian O.; Sapino, Anna; Rakha, Emad A.
14	Tumor types derived from epithelial and myoepithelial cell lines of R3230AC rat mammary carcinoma.	1992	SAPINO A ;PAPOTTI M ;SANFILIPPO B ;GUGLIOTTA P ;BUSSOLATI G
15	[Tumor samples as a tool for large-scale monitoring of antigen-specific lymphocytes in gastric and colorectal neoplasms]	1999	MATERA L ;GALETTO A ;CONTARINI M ;SAPINO A ;CONSALVO M ;CASSONI P ;MORO F ;MUSSA B ;MUSSA A
16	Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison	2010	Redana S; Donadio M; Nolè F; Jacomuzzi ME; Beano A; Martinello R; Sapino A; Viale G; Aglietta M; Montemurro F.
17	Towards a formalin-free hospital. Levels of 15-F2t-isoprostane and malondialdehyde to monitor exposure to formaldehyde in nurses from operating theatres	2016	Bellisario, Valeria; Mengozzi, Giulio; Grignani, Elena; Bugiani, Massimiliano; Sapino, Anna; Bussolati, Gianni; Bono, Roberto
18	TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin. TOP2A as marker of response to PLD in ovarian cancer	2015	Erriquez, J.; Becco, P.; Olivero, M.; Ponzone, R.; Maggiorotto, F.; Ferrero, A.; Scalzo, M.S.; Canuto, E.M.; Sapino, A.; Verdun di Cantogno, L.; Bruna, P.; Aglietta, M.; Di Renzo, M.F.; Valabrega, G.
19	“To Be or Not to Be in a Good Shape”: Diagnostic and Clinical Value of Nuclear Shape Irregularities in Thyroid and Breast CancerCancer Biology and the Nuclear Envelope	2014	Gianni Bussolati;Francesca Maletta;Sofia Asioli;Laura Annaratone;Anna Sapino;Caterina Marchiò
20	A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue	2014	Veronique M Neumeister;Fabio Parisi;Allison M England;Summar Siddiqui;Valsamo Anagnostou;Elizabeth Zarrella;Maria Vassilakopolou;Yalai Bai;Sasha Saylor;Anna Sapino;Yuval Kluger;David G Hicks;Gianni Bussolati;Stephanie Kwei;David L Rimm